Results 101 to 110 of about 362 (162)

Increased levels of tumor necrosis factor-alpha in rat with traumatic brain injury after NeuroAid (MLC 901) administration. [PDF]

Surg Neurol Int
Rohadi, Priyanto B, Islam AA, Hatta M, Bukhari A, Rozikin, Eka Putra IWGA, Abdurrosid LM, Prihastomo KT.   +8 more
europepmc   +1 more source

10th Anniversary of the Asia Pacific Stroke Organization: State of Stroke Care and Stroke Research in the Asia-Pacific. [PDF]

Cerebrovasc Dis Extra, 2022
Tan KS, Yoon BW, Lin RT, Mehndiratta MM, Suwanwela NC, Venketasubramanian N.   +5 more
europepmc   +1 more source

Evaluation of Neuroprotective and Neuroregenerative Potential of NeuroAiD™ II(MLC901) in a Rat Model of Kainic Acid-Induced Spinal Cord Injury. [PDF]

Mol Neurobiol
Anjum A, Yazid MD, Daud MF, Idris J, Ng AMH, Naicker AS, Ismail OHR, Athi Kumar RK, Lokanathan Y.   +8 more
europepmc   +1 more source

New Directions in Treatments Targeting Stroke Recovery. [PDF]

, 2018
Cramer, Steven C, Finklestein, Seth P, Lin, David J   +2 more
core  

Facilitation of neurological recovery in a complete spinal cord injury with NeuroAiD: case report. [PDF]

Spinal Cord Ser Cases
Zainudin MF, Abu Hassan SA, Khin NY.
europepmc   +1 more source

Pharmacological Treatment of Acute Ischemic Stroke [PDF]

, 2013
Cohen-Minian, Yael, Ibarra, Antonio, Mestre, Humberto, Zajarias-Fainsod, Daniel   +3 more
core   +2 more sources

Role of the Treatment of Post-Concussion Syndrome in Preventing Long-Term Sequela Like Depression: A Systematic Review of the Randomized Controlled Trials. [PDF]

Cureus, 2021
Dhandapani TPM, Garg I, Tara A, Patel JN, Dominic JL, Yeon J, Memon MS, Gergal Gopalkrishna Rao SR, Bugazia S, Khan S.   +9 more
europepmc   +1 more source

A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury. [PDF]

PLoS One
Pilipenko PI, Ivanova AA, Kotsiubinskaya YV, Grigoryeva VN, Khrulev AY, Skorokhodov AV, Gavrik MM, Mkrtchan NN, Majdan M, Valkovic P, Rabarova D, Barker-Collo S, Jones K, Feigin VL.   +13 more
europepmc   +1 more source

Use of MLC901 in cerebral venous sinus thrombosis: Three case reports. [PDF]

World J Clin Cases
Arsovska AA, Venketasubramanian N.
europepmc   +1 more source

Cost-effectiveness of MLC601 in post-stroke functional recovery compared with placebo - the CHIMES & CHIMES-E studies. [PDF]

BMC Health Serv Res
Chen CLH, Chai JH, Pokharkar YM, Venketasubramanian N.   +3 more
europepmc   +1 more source